ctrl K

Zentalis Pharmaceuticals ... (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

1.46

0.04 (2.82%)

At close: May 01, 2025, 3:59 PM

1.50

2.61%

Pre-market: May 02, 2025, 09:07 AM EDT

Zentalis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	67.42M	n/a	n/a	n/a	n/a	n/a	14K
Cost of Revenue	n/a	1.39M	1.43M	544K	160K	111K	n/a
Gross Profit	67.42M	-1.39M	-1.43M	-544K	-160K	-111K	14K
Operating Income	-191.19M	-248.99M	-227.29M	-216.54M	-118.79M	-46.84M	-23.78M
Interest Income	n/a	n/a	2.26K	1.31K	1.24K	498K	355K
Pretax Income	-165.69M	-276.89M	-221.3M	-164.56M	-118.1M	-46.36M	-23.43M
Net Income	-165.84M	-292.19M	-220.83M	-164.26M	-118.55M	-46.38M	-21.07M
Selling & General & Admin	87.11M	59.4M	54.55M	40.94M	33.89M	8.46M	4.88M
Research & Development	167.77M	189.59M	172.73M	175.6M	84.9M	38.39M	18.92M
Other Expenses	3.74M	n/a	n/a	n/a	n/a	-16K	n/a
Operating Expenses	258.62M	252.55M	227.29M	216.54M	118.79M	46.84M	23.8M
Interest Expense	n/a	n/a	2.58M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	258.62M	253.94M	227.29M	216.54M	118.79M	46.84M	23.8M
Income Tax Expense	177K	-601K	-469K	-297K	444K	15K	4K
Shares Outstanding (Basic)	71.08M	65.41M	52.86M	42.69M	41.04M	35.88M	18.06M
Shares Outstanding (Diluted)	71.08M	65.41M	52.86M	42.69M	41.04M	35.88M	18.06M
EPS (Basic)	-2.33	-4.47	-4.18	-3.85	-2.89	-1.29	-1.17
EPS (Diluted)	-2.33	-4.47	-4.18	-3.85	-2.89	-1.29	-1.17
EBITDA	-191.19M	-275.5M	-219.87M	-164.01M	-117.94M	-46.73M	-23.73M
EBIT	-187.46M	-276.89M	-221.3M	-164.56M	-118.1M	-46.36M	-23.78M
Depreciation & Amortization	1.29M	1.39M	1.43M	544K	160K	111K	51.49K